Mitigation of Health Effects in Pregnant Women by Reducing Exposure to Heat and Air Pollution
Condition(s) studied
Investigational drug(s) / intervention(s)
Heat intervention: The participants in this group of intervention will receive timely personal alerts for high temperatures and specific recommendations to reduce exposure to heat by changing patterns of time spent and physical activity performed outdoors, regulating indoor temperature using fans and/or air conditioning devices, as well as recommendations for mitigation of heat-related health effects (hydration, body cooling) in written and animated format, through mobile phones, web application and online tools to be developed by the project research team
Heat and air pollution mitigation intervention: The participants in this intervention group will receive alerts and recommendations as in group "Heat intervention" and, in addition, continuously use air cleaners with HEPA filters for removing PM from indoor air in their residences and workplaces.
Study summary
The goal of this clinical trial is to assess the effectiveness of an intervention (combination of behavioural recommendations and technical measures) in reducing personal exposure to heat and air pollution and related health effects in pregnant women.
The main questions it aims to answer are:
* Does the intervention (combination of behavioral recommendations for heat mitigation) reduce personal ambient temperature exposure, measured using a wearable device (iButton)?
* Does the intervention (combination of behavioral recommendations for air pollution mitigation and use of indoor air cleaners) reduce indoor exposure to air pollution, measured using indoor air quality sensors (Purple Air)?
* Does the intervention (combination of behavioral recommendations for heat mitigation) reduce sleep difficulties experienced by pregnant women, measured using the Pittsburgh Sleep Quality Index?
Researchers will compare measurements between pregnant women carrying out their daily activities in the absence of intervention (control group), those carrying out their daily activities with behavioural recommendations (recommendation intervention group) and those carrying out their daily activities with both behavioural recommendations for heat mitigation and continuous use of indoor air cleaners in their house (heat and air pollution mitigation intervention group) to see if changes in temperature exposure and sleep are different between intervention groups.
Participants will:
* Wear the wearable devise for continuous personal ambient temperature monitoring (ibutton) daily for a period of three months
* Have their core temperature measured using an eCelsius medical capsule in three repeated assessments
* Complete the Pittsburgh Sleep Quality Index questionnaire in three repeated assessments
* Provide samples of urine and blood biomarkers in three repeated assessments.
Eligibility
Primary outcome measure(s)
- Pittsburgh Sleep Quality Index (PSQI) — The PSQI will be assessed at baseline, middle (after 1 month), and at end of observation period (after 2 months).
The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a one-month time interval. The PSQI is commonly used in both clinical and research settings to evaluate various aspects of sleep. It is a valuable tool for assessing sleep quality as it captures multiple dimensions of sleep, including both subjective experiences and objective parameters. Higher scores indicate poorer sleep quality, with a score greater than 5 suggesting significant sleep difficulties.
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| Medical School, University of Cyprus | Limassol | Cyprus | Recruiting |
| Azienda Ospedaliera Di Rilievo Nazionale Garibaldi Catania | Catania | Italy | Recruiting |
| Azienda Ospedaliera Di Rilievo Nazionale Garibaldi Catania | Catania | Italy | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07609433 on ClinicalTrials.gov ↗ ← All trials in Italy